IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
The iShares Global Healthcare ETF and the State Street SPDR S&P Pharmaceuticals ETF offer different approaches to investing in the healthcare sector. The iShares ETF provides broad sector coverage, according to Nasdaq Markets.
The iShares Global Healthcare ETF offers broad sector diversification and lower volatility, while the State Street SPDR S&P Pharmaceuticals ETF provides concentrated exposure to US drugmakers, as per Motley Fool.
These two funds differ in geographical reach, concentration, and historical risk profiles. The iShares ETF has a higher dividend yield than the State Street SPDR S&P Pharmaceuticals ETF, Nasdaq Markets reports.
Brief written by urgent.news from Nasdaq Markets, Motley Fool — 2 reports on this story. Machine-written — may contain errors; check the original before relying on it.
